Fumio Sagami

532 total citations
44 papers, 410 citations indexed

About

Fumio Sagami is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Fumio Sagami has authored 44 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cancer Research and 9 papers in Pharmacology. Recurrent topics in Fumio Sagami's work include Carcinogens and Genotoxicity Assessment (13 papers), DNA Repair Mechanisms (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Fumio Sagami is often cited by papers focused on Carcinogens and Genotoxicity Assessment (13 papers), DNA Repair Mechanisms (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). Fumio Sagami collaborates with scholars based in Japan and United States. Fumio Sagami's co-authors include Shigeki Sawada, Atsushi Hakura, Shoji Asakura, Piero Tirone, Takashi Mikami, Yasuyuki Okuda, Kazuo Tsukidate, Jiro Sonoda, William Kerns and Satoru Hosokawa and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Fumio Sagami

42 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fumio Sagami Japan 12 136 117 53 51 49 44 410
Z Polívková Czechia 13 190 1.4× 171 1.5× 21 0.4× 46 0.9× 23 0.5× 28 461
Keisuke Ozaki Japan 15 291 2.1× 154 1.3× 32 0.6× 63 1.2× 123 2.5× 42 677
D. Lovell United Kingdom 10 178 1.3× 154 1.3× 35 0.7× 55 1.1× 54 1.1× 20 477
M. Lans Belgium 13 212 1.6× 107 0.9× 36 0.7× 18 0.4× 75 1.5× 30 437
Lucy Fraiser United States 5 133 1.0× 38 0.3× 51 1.0× 17 0.3× 70 1.4× 6 457
Stewart MacLeod United States 12 236 1.7× 159 1.4× 61 1.2× 54 1.1× 106 2.2× 17 512
H. R. Prasanna United States 11 218 1.6× 125 1.1× 43 0.8× 32 0.6× 29 0.6× 34 582
Augustine Chuang United States 13 130 1.0× 80 0.7× 95 1.8× 29 0.6× 45 0.9× 28 469
G. R. Wasson United Kingdom 10 181 1.3× 97 0.8× 13 0.2× 48 0.9× 31 0.6× 11 390
Gregory L. Weber United States 12 188 1.4× 40 0.3× 29 0.5× 39 0.8× 68 1.4× 20 480

Countries citing papers authored by Fumio Sagami

Since Specialization
Citations

This map shows the geographic impact of Fumio Sagami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Sagami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Sagami more than expected).

Fields of papers citing papers by Fumio Sagami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Sagami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Sagami. The network helps show where Fumio Sagami may publish in the future.

Co-authorship network of co-authors of Fumio Sagami

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Sagami. A scholar is included among the top collaborators of Fumio Sagami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Sagami. Fumio Sagami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sagami, Fumio, et al.. (2002). Study Monitor. Introduction of the Surveillance for Outsourcing Non-Clinical Studies and Summary of Toxicology.(GENERAL SESSION BY ORAL PRESENTATION)(MINI SYMPOSIUM : CONSIDERATION OF OUTSOURCINGS AND MONITORING IN NON-CLINICAL STUDY(CURRENT SURVEY)). The Journal of Toxicological Sciences. 27(4). 351. 1 indexed citations
2.
Hakura, Atsushi, et al.. (2000). Comparison of the mutational spectra of the lacZ transgene in four organs of the Muta™Mouse treated with benzo[a]pyrene: target organ specificity. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 447(2). 239–247. 22 indexed citations
3.
Aoki, Toyohiko, et al.. (2000). Hepatic drug metabolizing enzymes induced by clofibrate in rasH2 mice. Toxicology Letters. 115(3). 223–229. 7 indexed citations
4.
Sagami, Fumio, et al.. (2000). Auto-induction of E5110 metabolism, a novel non-steroidal anti-inflammatory drug, during toxicokinetic studies in beagle dogs.. The Journal of Toxicological Sciences. 25(1). 1–10. 5 indexed citations
5.
6.
Hakura, Atsushi, et al.. (1999). MUTAGENICITY STUDY OF GADOBENATE DIMEGLUMINE FORMULATION (E7155) (1) : REVERSE MUTATION ASSAYS IN S.TYPHIMURIUM AND E.COLI TESTER STRAINS. The Journal of Toxicological Sciences. 24(SupplementI). 89–94. 2 indexed citations
7.
Sawada, Shigeki, et al.. (1999). MUTAGENICITY STUDY OF GADOBENATE DIMEGLUMINE FORMULATION (E7155) (3) : MICRONUCLEUS TEST IN RAT BONE MARROW CELLS. The Journal of Toxicological Sciences. 24(SupplementI). 103–106. 4 indexed citations
8.
Okada, Futoshi, et al.. (1999). REPRODUCTIVE AND DEVELOPMENTAL TOXICITY STUDY OF GADOBENATE DIMEGLUMINE FORMULATION (E7155) (1) : FERTILITY STUDY IN MALE RATS BY INTRAVENOUS ADMINISTRATION. The Journal of Toxicological Sciences. 24(SupplementI). 61–69. 7 indexed citations
9.
10.
Sagami, Fumio, et al.. (1999). GENERAL TOXICITY STUDY OF GADOBENATE DIMEGLUMINE FORMULATION (E7155) (3) : 4-WEEK REPEATED DOSE INTRAVENOUS TOXICITY STUDY FOLLOWED BY 4-WEEK RECOVERY PERIOD IN RATS. The Journal of Toxicological Sciences. 24(SupplementI). 19–39. 5 indexed citations
11.
Hakura, Atsushi, Jiro Sonoda, Takashi Mikami, et al.. (1999). Multiple organ mutation in the lacZ transgenic mouse (Muta™ Mouse) 6 months after oral treatment (5 days) with benzo[a]pyrene. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 426(1). 71–77. 22 indexed citations
12.
Sawada, Shigeki, et al.. (1999). MUTAGENICITY STUDY OF GADOBENATE DIMEGLUMINE FORMULATION (E7155) (2) : CHROMOSOME ABERRATION TEST WITH HUMAN LYMPHOCYTES IN CULTURE. The Journal of Toxicological Sciences. 24(SupplementI). 95–101. 4 indexed citations
13.
Matsubara, Yoshihiro, et al.. (1998). MANUAL METHOD FOR QUALITATIVE AND QUANTITATIVE ASSESSMENT OF MALE REPRODUCTIVE EFFECTS IN RATS. The Journal of Toxicological Sciences. 23. 310. 1 indexed citations
14.
Imai, Toshio, et al.. (1998). Giant Cell Tumor of Bone in an Aged Fischer 344 Rat. Toxicologic Pathology. 26(6). 802–805. 5 indexed citations
15.
Sawada, Shigeki, et al.. (1997). Inhibition of sulfotransferase affecting in vivo genotoxicity and DNA adducts induced by safrole in rat liver. Teratogenesis Carcinogenesis and Mutagenesis. 17(6). 327–337. 26 indexed citations
16.
Hakura, Atsushi, et al.. (1996). Mutagenicity of dihydroxybenzenes and dihydroxynaphthalenes for Ames Salmonella tester strains. Mutation Research/Genetic Toxicology. 371(3-4). 293–299. 19 indexed citations
17.
Esato, Kensuke, Akinobu Furutani, Norio Akiyama, et al.. (1996). Effect of E5510 on Anastomotic Intimal Hyperplasia and Platelet Aggregation in Dogs. Journal of Cardiovascular Pharmacology. 27(6). 824–830. 5 indexed citations
18.
Kato, Ryuichi, David Case, Kosei NODA, et al.. (1993). Toxicokinetics: Its significance and practical problems.. The Journal of Toxicological Sciences. 18(4). 211–238. 3 indexed citations
19.
Tsukidate, Kazuo, Fumio Sagami, Takeo Horie, et al.. (1989). Induction of cytochrome P-450 isozymes by chromanamine derivatives in rat liver. Xenobiotica. 19(8). 901–912. 3 indexed citations
20.
Suzuki, Yasuo, Yoshio Hirabayashi, Fumio Sagami, & Makoto Matsumoto. (1988). Gangliosides in the blood plasma: levels of ganglio-series gangliosides in the plasma after administration of brain gangliosides. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 962(3). 277–281. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Z Polívková Breakdown of academic impact, for papers by Keisuke Ozaki Breakdown of academic impact, for papers by D. Lovell Breakdown of academic impact, for papers by M. Lans Breakdown of academic impact, for papers by Lucy Fraiser Breakdown of academic impact, for papers by Stewart MacLeod Breakdown of academic impact, for papers by H. R. Prasanna Breakdown of academic impact, for papers by Augustine Chuang Breakdown of academic impact, for papers by G. R. Wasson Breakdown of academic impact, for papers by Gregory L. Weber
Rankless by CCL
2026